Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement COPENHAGEN, Denmark; December 3, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 10,355 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 554 shares at DKK 962.00,3,436 shares at DKK 1,025.00,4,942 shares at DKK 1,032.00,305 shares at DKK 1,050.00, and1,118 sha ...